Drugs / ALTROPANE®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00397228 | Nov 2006 → Dec 2011 | Parkinson disease | Molecular NeuroImaging | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALTROPANE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00397228 ↗ |
| Modality | Diagnostic / imaging agent | “ALTROPANE® SPECT imaging” NCT00397228 ↗ |